Company Filing History:
Years Active: 2019-2021
Title: The Innovative Contributions of Bernard Calandra
Introduction
Bernard Calandra is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. With a total of two patents to his name, Calandra's work focuses on the development of fusion molecules that have important applications in medical diagnostics and therapeutics.
Latest Patents
Calandra's latest patents revolve around fusion molecules that exhibit binding specificity for pyoverdine types I, II, and III, as well as pyochelin. These fusion molecules are designed for various applications, including diagnostic and therapeutic uses. They aim to inhibit or reduce the growth of biofilm infections and to prevent or treat diseases associated with such infections. Additionally, his patents detail methods for producing these fusion molecules, along with compositions and kits that incorporate them. The inventions also include nucleic acid molecules that encode the described fusion molecules.
Career Highlights
Throughout his career, Bernard Calandra has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Sanofi and Pieris Pharmaceuticals GmbH, where he has contributed to various innovative projects and research initiatives.
Collaborations
Calandra has collaborated with several professionals in his field, including Carsten Corvey and Heike Stump. These collaborations have further enhanced his research and development efforts, leading to advancements in the applications